Medi Assist Healthcare Services Ltd

- Medi Assist expects continued growth driven by expanded partnerships and increasing health insurance penetration in India. - Group segment premiums grew ~14.7-15% YoY; retail premiums saw a 31% YoY growth, indicating strong momentum. - Margin improvements are expected with adjusted steady-state margins targeting around 23%, excluding one-time expenses. - The company is focused on improving operational efficiency via hubs of excellence and AI-driven fraud prevention, delivering 2.5x growth in savings to insurers. - Acquisition of new insurers and integration of acquisitions like Paramount aim to boost scale and profitability. - Return on Net Worth for 9 months is strong at 30.2% (annualized 17.6%), and RoCE is 14% (annualized 18.7%), showing healthy capital efficiency. - Enabling capital raises (such as the 350 CR fundraise) support strategic growth initiatives. - Overall, results and commentary indicate a positive outlook for earnings, operating profits, and EPS growth fueled by market expansion, technology, and improved claim management.

- As of December 31, 2024, the contract liability (order book equivalent) stood at INR 227 crores, indicating a healthy pipeline of unrecognized revenue. - No sharp decline or significant change in yield from the contract liability was observed. - The company expects some lag in revenue recognition due to the nature of revenue over the policy periods. - Growth in premiums was strong, with a 16.6% year-on-year increase in Premiums Under Management (PUM), showing positive momentum for future business inflows. - The company continues to add new insurers and expand portfolios, especially in Retail and Government segments, which would contribute to future order inflows. - The Paramount acquisition is pending regulatory approval, expected within the current quarter, which may add to order backlog and business volume once closed.

- The company has taken approval for a significant fundraising (enabling resolution) to support future growth. - Specific details on timing and exact usage of the funds have not been disclosed yet, as per regulatory guidelines. - The fundraise is intended to enable growth opportunities over the next few years, including deployments related to the announced Paramount acquisition. - The company will update investors as approvals are received from the Board and shareholders. - No explicit information was provided about whether the fundraising will be through debt or equity; it's positioned as a general capital structure and allocation strategy evaluation.

- A significant fundraise approval of INR 350 crores has been taken as an enabling resolution for future growth and capital deployment (Page 9). - The fundraise is intended to support strategic initiatives and growth, including the announced Paramount acquisition (Page 9). - No specific timing or detailed use of funds is disclosed yet; updates will be provided as Board and shareholder approvals progress (Page 9). - Medi Assist continues to invest in technology and AI capabilities, including their proprietary AI for predicting out-of-pocket expenses and AI-powered fraud detection, which supports operational efficiency and claims processing (Pages 6, 5). - Creation of hubs of excellence for claims processing to improve operational efficiency (Page 5).

- Premium under management grew 16.6% YoY as of December 31, 2024, with Group premiums growing ~15% YoY and Retail premiums growing 31% YoY. - Addition of three new private insurers in Retail portfolio expected to increase business as renewals progress. - Group segment shows over 40% YoY growth in premiums administered by private and SAHI insurers. - Government business growth is aligned with industry growth, driven by expansion and performance focus in government schemes. - Industry tailwinds include economic growth, increasing employment (including gig economy), and government initiatives advancing insurance penetration. - Focus on improving customer experience, technology automation, fraud prevention, and medical inflation control positions the company for sustainable growth. - Revenue from contracts growing ~13% YoY (excluding government), contract liability remains healthy. - Margin improvement expected post one-time expenses; steady-state margins projected near 23%. Overall, the company expects steady, double-digit revenue growth fueled by expansion across Group, Retail, and Government segments with enhanced insurer partnerships.